Dublin, Ireland
Summary
This organization specializes in providing outsourced clinical development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. It offers a comprehensive range of solutions including clinical trials, consulting, and strategic services across various therapeutic areas and sectors. The organization focuses on enhancing drug development processes through innovative technologies and patient-centric approaches.
Based on content on iconplc.com
catalent.com
Somerset, NJ
Pharmaceutical and Biotechnology Contract Development and Manufacturing
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
24.4 years — Since Aug 2000
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
541711
SIC 4 Digit Code
8731
SIC 2 Digit Code
87
Industry
1. Clinical Research and Development
2.
Vendor
Source
Microsoft
TXT Record
Adobe identity provider
TXT Record
Adobe Sign
TXT Record
Amazon SES
TXT Record
Apple
TXT Record
Atlassian
TXT Record
Cisco CI
TXT Record
TXT Record
Miro
TXT Record
OneTrust
TXT Record
Pardot
TXT Record
TeamViewer
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2000 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2001 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2002 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2003 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2004 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2009 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2010 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2011 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2012 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2015 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|